Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PetVivo Holdings Inc PETV

Healthcare Medical Devices
PetVivo Holdings, Inc. is a biomedical device company, which is focused on the manufacturing, commercialization and licensing of medical devices and therapeutics for animals. The Company's lead product Spryng with OsteoCushion technology, is a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses... see more

Recent & Breaking News (OTCPK:PETV)

PetVivo Reports Second Quarter of Fiscal 2024 Financial Results

GlobeNewswire November 14, 2023

PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE SECOND QUARTER ENDED SEPTEMBER 30, 2023

GlobeNewswire November 9, 2023

PetVivo Holdings, Inc. Announces Scheduled Presentations by PetVivo Veterinarians at the American Association of Equine Practitioners Convention in San Diego, California

GlobeNewswire November 2, 2023

PetVivo Holdings, Inc. Encouraged Over Positive Response Received at 2023 American College of Veterinary Surgeons Conference

GlobeNewswire October 25, 2023

PetVivo Holdings, Inc. Announces Presentation of Clinical Study Results at the American College of Veterinary Surgeons Conference in Louisville, Kentucky

GlobeNewswire October 12, 2023

PetVivo Holdings, Inc. to Exhibit at 2023 American College of Veterinary Surgeons Conference

GlobeNewswire October 10, 2023

PetVivo Holdings Inc. Announces Participation in The ThinkEquity Conference

Newsfile October 9, 2023

PETVIVO HOLDINGS, INC. ANNOUNCES PARTICIPATION AT THE H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE SEPTEMBER 11-13, 2023

GlobeNewswire September 5, 2023

PetVivo Holdings, Inc. Achieves National Distribution of Spryng to More than 500 Veterinary Clinics in 49 States

GlobeNewswire August 28, 2023

PetVivo Recieves Notice of Allowance from United States Patent and Trademark Office for Key Patent Application

GlobeNewswire August 17, 2023

PetVivo Reports First Quarter of Fiscal 2024 Financial Results

GlobeNewswire August 10, 2023

PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE FIRST QUARTER ENDED June 3, 2023

GlobeNewswire August 7, 2023

PetVivo Holdings, Inc. Achieves National Distribution of Spryng to More than 450 Veterinary Clinics

GlobeNewswire July 20, 2023

PETVIVO HOLDINGS, INC. ANNOUNCES RESCHEDULED EARNINGS CALL FOR THE YEAR ENDED MARCH 31, 2023

GlobeNewswire June 29, 2023

PetVivo Reports Fiscal 2023 Full Year Financial Results

GlobeNewswire June 29, 2023

Dr. Jeremy Caplin Joins PetVivo Holdings, Inc. as the Director of Research

GlobeNewswire June 27, 2023

PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2023 ENDED MARCH 31, 2023

GlobeNewswire June 26, 2023

PetVivo Holdings, Inc. Begins Process to Pursue Approval of Biomatrix Particulate Technology for Initial Human Indication

GlobeNewswire June 21, 2023

Dr. Thomas Yarbrough Joins PetVivo Holdings, Inc. as the Senior Research Director

GlobeNewswire June 5, 2023

Dr. Maureen Dower Joins PetVivo Holdings, Inc. as a Senior Technical Services Veterinarian

GlobeNewswire June 1, 2023